Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands.
Ann Surg Oncol. 2012 Aug;19(8):2428-34. doi: 10.1245/s10434-012-2294-6. Epub 2012 Mar 7.
Thirty-day mortality after surgery for colorectal cancer may vastly underestimate 1-year mortality. This study aimed to quantify the excess mortality in the first postoperative year of stage I-III colorectal cancer patients and to identify risk factors for excess mortality.
All 2,131 patients who were operated with curative intent for stage I-III colorectal cancer in the western region of the Netherlands between January 1, 2006, and December 31, 2008, were analyzed. Thirty-day mortality and relative survival were calculated. In addition, relative excess risk (RER) of death was estimated by a multivariable model.
Thirty-day mortality was 4.9%. One-year mortality was 12.4%. Risk factors for excess mortality in the first postoperative year for colon cancer patients were emergency surgery (excess mortality 29.7%, RER 2.5, 95% confidence interval 2.5-5.0), a Charlson score of >1 (excess mortality 12.6%, RER 2.3, 95% confidence interval 1.5-3.7), stage II or III disease (excess mortality 14.9%, RER 3.9, 95% confidence interval 1.9-8.1), and postoperative adverse events (excess mortality 22.6%, RER 2.1, 95% confidence interval 1.4-3.2).
The 30-day mortality rate highly underestimates the risk of dying in the first year after surgery, with excess 1-year mortality rates varying from 15 to 30%. This excess mortality was especially prominent in patients with comorbidities, higher stages of disease, emergency surgery, and postoperative surgical complications.
结直肠癌手术后 30 天的死亡率可能严重低估了 1 年的死亡率。本研究旨在量化 I-III 期结直肠癌患者术后第一年的超额死亡率,并确定超额死亡率的危险因素。
分析了 2006 年 1 月 1 日至 2008 年 12 月 31 日期间在荷兰西部地区接受 I-III 期结直肠癌根治性手术的 2131 例患者。计算了 30 天死亡率和相对生存率。此外,通过多变量模型估计了死亡的相对超额风险(RER)。
30 天死亡率为 4.9%。1 年死亡率为 12.4%。结肠癌患者术后第 1 年死亡的危险因素为急诊手术(超额死亡率 29.7%,RER 2.5,95%置信区间 2.5-5.0)、Charlson 评分>1(超额死亡率 12.6%,RER 2.3,95%置信区间 1.5-3.7)、II 期或 III 期疾病(超额死亡率 14.9%,RER 3.9,95%置信区间 1.9-8.1)和术后不良事件(超额死亡率 22.6%,RER 2.1,95%置信区间 1.4-3.2)。
30 天死亡率高度低估了手术后第 1 年死亡的风险,1 年超额死亡率从 15%到 30%不等。这种超额死亡率在合并症、疾病分期较高、急诊手术和术后手术并发症的患者中尤为突出。